Randomized, Double-Blind, Placebo-Controlled, Safety and Immunogenicity Study of 4 Formulations of Anthrax Vaccine Adsorbed Plus CPG 7909 (AV7909) in Healthy Adult Volunteers

A new anthrax vaccine that could accelerate the immune response and possibly reduce the number of injections needed for protection would be desirable in a post-exposure setting. This Phase 1 study compared the safety and immunogenicity of 2 IM doses (Days 0 and 14) of 4 formulations of AV7909 (AVA p...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Hopkins, Robert J., Daczkowski, Nancy F., Kaptur, Paulina E., Muse, Derek, Sheldon, Eric, LaForce, Craig, Sari, Suha, Rudge, Thomas L., Bernton, Edward
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3687017/
https://ncbi.nlm.nih.gov/pubmed/23701746
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2013.04.063
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items